McLeod, S. M.; Kimsey, H. H.; Davis, B. M.; Waldor, M. K. (2005). "CTXφ and Vibrio cholerae: exploring a newly recognized type of phage-host cell relationship". Molecular Microbiology57: 347–356. PMID15978069. doi:10.1111/j.1365-2958.04676.x.
Krishnamurthy SR, Wang D (2018). "Extensive conservation of prokaryotic ribosomal binding sites in known and novel picobirnaviruses". Virology516: 108–114. PMID29346073. doi:10.1016/j.virol.2018.01.006.
Kutter, Elizabeth; De Vos, Daniel; Gvasalia, Guram; Alavidze, Zemphira; Gogokhia, Lasha; Kuhl, Sarah; Abedon, Stephen (1 January 2010). "Phage Therapy in Clinical Practice: Treatment of Human Infections". Current Pharmaceutical Biotechnology11 (1): 69–86. PMID20214609. doi:10.2174/138920110790725401.
Rhoads, DD; Wolcott, RD; Kuskowski, MA; Wolcott, BM; Ward, LS; Sulakvelidze, A (June 2009). "Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial". Journal of Wound Care18 (6): 237–8, 240–3. PMID19661847. doi:10.12968/jowc.2009.18.6.42801.
Wright, A.; Hawkins, C.H.; Änggård, E.E.; Harper, D.R. (August 2009). "A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy". Clinical Otolaryngology34 (4): 349–357. PMID19673983. doi:10.1111/j.1749-4486.2009.01973.x.
Mokrousov I (2009). "Corynebacterium diphtheriae: genome diversity, population structure and genotyping perspectives". Infection, Genetics and Evolution9 (1): 1–15. PMID19007916. doi:10.1016/j.meegid.2008.09.011.
Lekunberri, Itziar; Subirats, Jessica; Borrego, Carles M.; Balcazar, Jose L. (2017). "Exploring the contribution of bacteriophages to antibiotic resistance". Environmental Pollution220 (Pt B): 981–984. PMID27890586. doi:10.1016/j.envpol.2016.11.059. hdl:10256/14115.
Mojica FJ, Rodriguez-Valera F (September 2016). "The discovery of CRISPR in archaea and bacteria". The FEBS Journal283 (17): 3162–69. PMID27234458. doi:10.1111/febs.13766.
Bouman, H.A.; Ulloa, O.; Scanlan, D.J.; Zwirglmaier, K.; Li, W.K.; Platt, T.; Stuart, V.; Barlow, R.; Leth, O.; Clementson, L.; Lutz, V. (2006). "Oceanographic basis of the global surface distribution of Prochlorococcus ecotypes". Science312 (5775): 918–921. Bibcode:2006Sci...312..918B. PMID16690867. doi:10.1126/science.1122692.
Strauss, James H.; Sinsheimer, Robert L. (July 1963). "Purification and properties of bacteriophage MS2 and of its ribonucleic acid". Journal of Molecular Biology7 (1): 43–54. PMID13978804. doi:10.1016/S0022-2836(63)80017-0.
Ackermann, H.-W.; Krisch, H. M. (6 April 2014). "A catalogue of T4-type bacteriophages". Archives of Virology142 (12): 2329–2345. PMID9672598. doi:10.1007/s007050050246.
Lekunberri, Itziar; Subirats, Jessica; Borrego, Carles M.; Balcazar, Jose L. (2017). "Exploring the contribution of bacteriophages to antibiotic resistance". Environmental Pollution220 (Pt B): 981–984. PMID27890586. doi:10.1016/j.envpol.2016.11.059. hdl:10256/14115.
McLeod, S. M.; Kimsey, H. H.; Davis, B. M.; Waldor, M. K. (2005). "CTXφ and Vibrio cholerae: exploring a newly recognized type of phage-host cell relationship". Molecular Microbiology57: 347–356. PMID15978069. doi:10.1111/j.1365-2958.04676.x.
Krishnamurthy SR, Wang D (2018). "Extensive conservation of prokaryotic ribosomal binding sites in known and novel picobirnaviruses". Virology516: 108–114. PMID29346073. doi:10.1016/j.virol.2018.01.006.
Kutter, Elizabeth; De Vos, Daniel; Gvasalia, Guram; Alavidze, Zemphira; Gogokhia, Lasha; Kuhl, Sarah; Abedon, Stephen (1 January 2010). "Phage Therapy in Clinical Practice: Treatment of Human Infections". Current Pharmaceutical Biotechnology11 (1): 69–86. PMID20214609. doi:10.2174/138920110790725401.
Rhoads, DD; Wolcott, RD; Kuskowski, MA; Wolcott, BM; Ward, LS; Sulakvelidze, A (June 2009). "Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial". Journal of Wound Care18 (6): 237–8, 240–3. PMID19661847. doi:10.12968/jowc.2009.18.6.42801.
Wright, A.; Hawkins, C.H.; Änggård, E.E.; Harper, D.R. (August 2009). "A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy". Clinical Otolaryngology34 (4): 349–357. PMID19673983. doi:10.1111/j.1749-4486.2009.01973.x.
Mokrousov I (2009). "Corynebacterium diphtheriae: genome diversity, population structure and genotyping perspectives". Infection, Genetics and Evolution9 (1): 1–15. PMID19007916. doi:10.1016/j.meegid.2008.09.011.
Lekunberri, Itziar; Subirats, Jessica; Borrego, Carles M.; Balcazar, Jose L. (2017). "Exploring the contribution of bacteriophages to antibiotic resistance". Environmental Pollution220 (Pt B): 981–984. PMID27890586. doi:10.1016/j.envpol.2016.11.059. hdl:10256/14115.
Mojica FJ, Rodriguez-Valera F (September 2016). "The discovery of CRISPR in archaea and bacteria". The FEBS Journal283 (17): 3162–69. PMID27234458. doi:10.1111/febs.13766.
Bouman, H.A.; Ulloa, O.; Scanlan, D.J.; Zwirglmaier, K.; Li, W.K.; Platt, T.; Stuart, V.; Barlow, R.; Leth, O.; Clementson, L.; Lutz, V. (2006). "Oceanographic basis of the global surface distribution of Prochlorococcus ecotypes". Science312 (5775): 918–921. Bibcode:2006Sci...312..918B. PMID16690867. doi:10.1126/science.1122692.
Strauss, James H.; Sinsheimer, Robert L. (July 1963). "Purification and properties of bacteriophage MS2 and of its ribonucleic acid". Journal of Molecular Biology7 (1): 43–54. PMID13978804. doi:10.1016/S0022-2836(63)80017-0.
Ackermann, H.-W.; Krisch, H. M. (6 April 2014). "A catalogue of T4-type bacteriophages". Archives of Virology142 (12): 2329–2345. PMID9672598. doi:10.1007/s007050050246.